These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

809 related items for PubMed ID: 18195566

  • 21. Reduced bone mineral density in human immunodeficiency virus-infected patients and its association with increased central adiposity and postload hyperglycemia.
    Brown TT, Ruppe MD, Kassner R, Kumar P, Kehoe T, Dobs AS, Timpone J.
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1200-6. PubMed ID: 15001610
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Bone mineral density remains stable in HAART-treated HIV-infected men over 2 years.
    Bolland MJ, Grey AB, Horne AM, Briggs SE, Thomas MG, Ellis-Pegler RB, Woodhouse AF, Gamble GD, Reid IR.
    Clin Endocrinol (Oxf); 2007 Aug; 67(2):270-5. PubMed ID: 17547686
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Osteoporosis and inflammatory bowel disease: prevalence and risk factors in Tunisian patients].
    Boubaker J, Feki M, Hsairi M, Fekih M, Kaabachi N, Filali A, Mebazaa A.
    Gastroenterol Clin Biol; 2003 Oct; 27(10):901-7. PubMed ID: 14631305
    [Abstract] [Full Text] [Related]

  • 27. Bone mass loss and vitamin D metabolism impairment in HIV patients receiving highly active antiretroviral therapy.
    Madeddu G, Spanu A, Solinas P, Calia GM, Lovigu C, Chessa F, Mannazzu M, Falchi A, Mura MS, Madeddu G.
    Q J Nucl Med Mol Imaging; 2004 Mar; 48(1):39-48. PubMed ID: 15195003
    [Abstract] [Full Text] [Related]

  • 28. [The impact of highly active antiretroviral therapy on bone mineral density in human immunodeficiency virus infected patients].
    Guo FP, Yu XB, Luo L, Han Y, Qiu ZF, Zuo LY, Li YL, Yu W, Li TS.
    Zhonghua Nei Ke Za Zhi; 2010 Aug; 49(8):649-52. PubMed ID: 20979781
    [Abstract] [Full Text] [Related]

  • 29. Prevalence of bone mineral density abnormalities and related risk factors in an ambulatory HIV clinic population.
    Guillemi S, Harris M, Bondy GP, Ng F, Zhang W, Lima VD, Michaels CE, Belzberg A, Montaner JS.
    J Clin Densitom; 2010 Aug; 13(4):456-61. PubMed ID: 20663695
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Bone mineral density of vegetarian and non-vegetarian adults in Taiwan.
    Wang YF, Chiu JS, Chuang MH, Chiu JE, Lin CL.
    Asia Pac J Clin Nutr; 2008 Aug; 17(1):101-6. PubMed ID: 18364334
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Prevalence of osteopenia and osteoporosis by central and peripheral bone mineral density in men with prostate cancer during androgen-deprivation therapy.
    Bruder JM, Ma JZ, Basler JW, Welch MD.
    Urology; 2006 Jan; 67(1):152-5. PubMed ID: 16413352
    [Abstract] [Full Text] [Related]

  • 35. Correlates of osteoporosis in chronic obstructive pulmonary disease: An underestimated systemic component.
    Graat-Verboom L, Spruit MA, van den Borne BE, Smeenk FW, Martens EJ, Lunde R, Wouters EF, CIRO Network.
    Respir Med; 2009 Aug; 103(8):1143-51. PubMed ID: 19304474
    [Abstract] [Full Text] [Related]

  • 36. Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors.
    Guaraldi G, Squillace N, Stentarelli C, Orlando G, D'Amico R, Ligabue G, Fiocchi F, Zona S, Loria P, Esposito R, Palella F.
    Clin Infect Dis; 2008 Jul 15; 47(2):250-7. PubMed ID: 18532884
    [Abstract] [Full Text] [Related]

  • 37. Bone mineral density in subjects using central nervous system-active medications.
    Kinjo M, Setoguchi S, Schneeweiss S, Solomon DH.
    Am J Med; 2005 Dec 15; 118(12):1414. PubMed ID: 16378792
    [Abstract] [Full Text] [Related]

  • 38. Prevalence of osteoporosis and factors affecting bone mineral density among postmenopausal Turkish women with type 2 diabetes.
    Anaforoglu I, Nar-Demirer A, Bascil-Tutuncu N, Ertorer ME.
    J Diabetes Complications; 2009 Dec 15; 23(1):12-7. PubMed ID: 18413190
    [Abstract] [Full Text] [Related]

  • 39. [Influence of long-term highly active antiretroviral therapy on bone mineral density in HIV/AIDS patients].
    Su YB, Xie J, Han Y, Qiu ZF, Li YL, Song XJ, Yu W, Li TS.
    Zhonghua Yi Xue Za Zhi; 2012 May 08; 92(17):1155-8. PubMed ID: 22883000
    [Abstract] [Full Text] [Related]

  • 40. Prevalence of osteopenia and osteoporosis in a normal female Puerto Rican population.
    Haddock L.
    P R Health Sci J; 1997 Sep 08; 16(3):241-4. PubMed ID: 9431560
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 41.